Last updated: November 5, 2023
Sponsor: East and North Hertfordshire NHS Trust
Overall Status: Active - Recruiting
Phase
N/A
Condition
Atrial Fibrillation
Chest Pain
Arrhythmia
Treatment
Thrombotic assessment
Clinical Study ID
NCT06124612
RD2023-21
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged 18 years or over
- Patients enrolled in OCEANIC-AF study
- Free from the exclusion criteria below
- The patient is willing and able to understand the Patient Information Sheet andprovide written informed consent
- The patient agrees to comply with the drawing of blood samples for the assessments.
Exclusion
Exclusion Criteria:
- Inability to provide valid informed consent
- Patients aged < 18 years of age
- Patients with significant neurological, hepatic, renal, endocrine, gastrointestinal,pulmonary, haemorrhagic, metabolic or other disease likely to confound the studyrequirements or analyses
- Patients with a history of substance abuse or signs or clinical features of activesubstance abuse or psychiatric disease
- Alcohol consumption above 21 units per week
- Any illness deemed significant by the investigator during the four (4) weeks precedingthe screening period of the study
- Any major bleeding diathesis or blood dyscrasia (platelets <70 x 109/l, Hb <80 g/dl,INR >1.4, APTT >x 2 UNL, leucocyte count <3.5 x 109/l, neutrophil count <1 x 109/l)
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Thrombotic assessment
Phase:
Study Start date:
November 03, 2023
Estimated Completion Date:
September 17, 2026
Study Description
Connect with a study center
Liverpool Heart and Chest Hospital
Liverpool,
United KingdomSite Not Available
East and North Herts NHS Trust
Stevenage,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.